| | | Single nucleotide variant (synonymous variant) | not provided | |
| | DNASE1L1, LOC130068869 +1 more (M1V) | Single nucleotide variant (missense variant +3 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (M1I) | Single nucleotide variant (missense variant +3 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (V5L) | Single nucleotide variant (missense variant +2 more) | not provided +3 more | |
| | DNASE1L1, LOC130068869 +1 more (K6N) | Single nucleotide variant (missense variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (synonymous variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (F9L) | Single nucleotide variant (missense variant +2 more) | 3-Methylglutaconic aciduria type 2 +1 more | |
| | DNASE1L1, LOC130068869 +1 more (P10S) | Single nucleotide variant (missense variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (P10R) | Single nucleotide variant (missense variant +2 more) | not provided +2 more | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (synonymous variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (P13S) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +1 more | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (synonymous variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (synonymous variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (synonymous variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (T16S) | Single nucleotide variant (missense variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 +2 more | |
| | TAFAZZIN, DNASE1L1 +1 more (W17C) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (T18I) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | TAFAZZIN, DNASE1L1 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 +2 more | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | not provided +2 more | |
| | DNASE1L1, LOC130068869 +1 more (G29R) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 +1 more | |
| | DNASE1L1, LOC130068869 +1 more (T30I) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | Cardiovascular phenotype +1 more | |
| | TAFAZZIN, DNASE1L1 +1 more (Y31C) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (F34I) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | GPathogenic/Likely pathogenic |
| | DNASE1L1, LOC130068869 +1 more (W39*) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | LOC130068869, TAFAZZIN +1 more (A42fs) | Deletion (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more (A42T) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, LOC130068869 +1 more | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | 3-Methylglutaconic aciduria type 2 | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | 3-Methylglutaconic aciduria type 2 | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | 3-Methylglutaconic aciduria type 2 | |
| | | Single nucleotide variant (no sequence alteration +1 more) | 3-Methylglutaconic aciduria type 2 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | 3-Methylglutaconic aciduria type 2 | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | 3-Methylglutaconic aciduria type 2 +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | 3-Methylglutaconic aciduria type 2 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, TAFAZZIN (Y56C +1 more) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | DNASE1L1, TAFAZZIN (M39I +1 more) | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | | Single nucleotide variant (5 prime UTR variant +2 more) | 3-Methylglutaconic aciduria type 2 | |
| | | Duplication | Oto-palato-digital syndrome, type II +3 more | |
| | | Duplication | 3-Methylglutaconic aciduria type 2 | |
| | ATP6AP1, DNASE1L1 +13 more | Duplication | 3-Methylglutaconic aciduria type 2 | |
| | | Deletion | Creatine transporter deficiency +6 more | |
| | | Duplication | Severe neonatal-onset encephalopathy with microcephaly | |
| | ATP6AP1, DNASE1L1 +13 more | Duplication | Heterotopia, periventricular, X-linked dominant +3 more | |
| | | Duplication | Heterotopia, periventricular, X-linked dominant +3 more | |
| | | Deletion | Dyskeratosis congenita | |
| | ATP6AP1, DNASE1L1 +10 more | Duplication | X-linked Emery-Dreifuss muscular dystrophy | |
| | ATP6AP1, DNASE1L1 +10 more | Duplication | not provided | |
| | | Duplication | Adrenoleukodystrophy | |
| | | Deletion | Spastic paraplegia +8 more | |
| | | Duplication | X-linked Emery-Dreifuss muscular dystrophy | |
| | | Deletion | 3-Methylglutaconic aciduria type 2 | |
| | | Deletion | 3-Methylglutaconic aciduria type 2 | |
| | | Duplication | Heterotopia, periventricular, X-linked dominant +4 more | |
| | | Duplication | X-linked Emery-Dreifuss muscular dystrophy | |
| | | Duplication | Frontometaphyseal dysplasia +3 more | |
| | | Deletion | X-linked Emery-Dreifuss muscular dystrophy | |
| | | Duplication | Heterotopia, periventricular, X-linked dominant +3 more | |
| | | Deletion | Adrenoleukodystrophy | |
| | | Duplication | 3-Methylglutaconic aciduria type 2 | |
| | ATP6AP1, DNASE1L1 +19 more | Duplication | Severe neonatal-onset encephalopathy with microcephaly | |